• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

GRAS Notices

  • Print
  • Share
  • E-mail
-

GRN No. 864

Substance: Bacillus coagulans SNZ 1969 spore preparation
Intended Use: Intended for use as an ingredient in non-exempt term infant formula a maximum level of 2 x 108 CFU/100mL of infant formula.
Basis: Scientific procedures
Notifier: Sanzyme Biologics Pvt. Ltd.
Plot No. 13, Sagar Society, Banjara Hills, Road Number 2 Hyderabad – 500 034, Telengana
INDIA
GRAS Notice (releasable information): GRN 864 (in PDF) (6.9 MB)
FDA's Letter: Pending

679663  

-
-